NYSE Post
  • Home
  • Business
  • Entertainment
  • Technology
  • Research
  • Sport
  • World Media
  • Health
  • USA
No Result
View All Result
  • Home
  • Business
  • Entertainment
  • Technology
  • Research
  • Sport
  • World Media
  • Health
  • USA
No Result
View All Result
NYSE Post
No Result
View All Result
Home Health

MannKind Corporation (NASDAQ:MNKD) shares decline by 4.10%

Kevin Goodings by Kevin Goodings
11/29/2022
in Health
Reading Time: 1 min read
0
0
SHARES
77
VIEWS
Share on FacebookShare on Twitter

Boston, MA, 08/06/2013 (nysepost) – MannKind Corp. of Valencia publicized on July 1 that it has entered into a protected financing with associates of Deerfield Management Company L.P., who have dedicated to purchase up to $160 million in senior secured notes. The notes will accumulate interest at a rate of 9.75% per annum until maturity in the year 2019. A part of the principal amount of the loan facility may be exchangeable into stocks of MannKind’s common stocks at the Deerfield’s option after a specified period following the discharge of data from the clinical trials.

The conversion value will be determined by the size weighted average price of the common share during the 20 trading days instantly preceding the conversion date. If the conversion price surpasses $6.67, no more than 6 million stocks may be distributed upon exchange; if the exchange price is less than $3.33, no more than 12 million stocks may be issued upon conversion; and if the conversion price is in the middle of these dollar amounts, no more than $40 million value of common stock may be supplied upon conversion. As part of the deal, Deerfield received from MannKind milestone privileges, which offer for the compensation of up to $90 million upon the event of assured strategic and sales milestones.

The stock had moved on to decrease by 4.10% to close at $7.95 on Monday, after the opening price at $8.29 per share. MannKind Corporation (NASDAQ:MNKD) had throughout the trading session moved between $7.91 and $8.29 per share and presently has 52 week lowest price at $1.82 and 52 week highest price at $8.33 per share. The market cap of the stock is at $2.31 billion with 290.88 million shares outstanding and 18% institutional ownership of capital. The trading volume on Monday was at 9.63 million shares on the stock and the average level is at 6.32 million shares per day.

Previous Post

Inovio Pharmaceuticals Incorporation (NYSEMKT:INO) has been basking with the glow of positive results

Next Post

Matthew Rhys In Masterpiece ‘Pemberley’; Jack Davenport In PBS ‘Breathless’

Next Post

Matthew Rhys In Masterpiece ‘Pemberley’; Jack Davenport In PBS ‘Breathless’

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

General Motors Company (NYSE:GM) confirms 1,000 job cuts in Brazil

11/29/2022

United States draws a line on protecting CIA-backed rebels in Syria

11/29/2022

EU leaders set June 30 deadline for new border force

11/29/2022

US Cuba Continue To Have Deep Differences on Human Rights

11/27/2022

325m Circuit Of Wales Plans in EBBW Vale Pass Vital Hurdle

11/29/2022

Sept 10 Apple Inc. (NASDAQ:AAPL) episode fuels talk of innovative iPhone introduction

11/28/2022

Open carry, guns on campus bills pass FL Senate commitees

11/29/2022

Hack the Pentagon: US military invites hackers to test security

11/29/2022

Teva To Buy Rrimsa for About 2.3 Billion

11/28/2022

Donald Trump Opens Commanding Lead in New CNN Poll

11/29/2022

Water Bears Have Super Resistant DNA

11/29/2022

University of Texas Medical Branch, Brazil reach deal on Zika vaccine

11/29/2022

The House of Representatives Against Supporting

11/28/2022

Scope Of Facebook Inc (NASDAQ:FB) In Mobile Ad Space

11/28/2022

Islamic State retaliates for drone killing, leaks credentials for 54K Twitter

11/29/2022

Pathologist is 1st defense witness in Gray trial

11/29/2022
logo

Our next winner could be in your inbox tomorrow!

  • About us
  • Disclaimer
  • Contact Us

Categories

  • Business
  • Entertainment
  • Health
  • Markets
  • Politics
  • Research
  • Sport
  • Technology
  • USA
  • World Media

Recent News

Chuck Hagel gets grilled by Republicans in Senate hearing

11/28/2022

Trump, still not conceding defeat, hails vaccine progress

11/28/2022

© 2007-2025 All rights reserved - NysePost.com

No Result
View All Result
  • Home

© 2007-2025 All rights reserved - NysePost.com

Go to mobile version